UNSPSC 85722549: Removal of nonautologous tissue substitute from left tarsal joint, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of nonautologous tissue substitute from left tarsal joint, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SPJ4KZ

UNSPSC 85722549 Removal of nonautologous tissue substitute from left tarsal joint, percutaneous endoscopic approach is a Commodity code that shows no recent state and local procurement activity aligned with its nominal scope. The six recent opportunities posted under this code—spanning independent medical evaluations for pension boards, surgical benefit carve-outs for municipal employees, occupational medical surveillance for a state ferry system, emergency medical services for detained youth, pharmacy benefit management, and temporary health professional staffing—do not involve orthopedic tissue removal procedures or joint-based surgical interventions. The opportunities instead reflect general health services procurement, benefits administration, and clinical staffing. This mismatch indicates either misclassification in the posting systems or that the code does not meaningfully describe current state and local buying activity in this domain.

State and local procurement offices in Arizona, California, Florida, and Washington have posted these health-services solicitations in recent weeks, but none target the specific procedural service the code nominally names. The City of Phoenix Retirement Office posted an RFP due October 16, 2026 for independent medical evaluation services; the City of Long Beach posted an RFP due October 7, 2026 for surgical benefit carve-outs across multiple procedure categories; and the Washington State Department of Transportation's Ferries division posted an RFP due October 9, 2026 for occupational medical surveillance. Without recent opportunities explicitly soliciting removal of nonautologous tissue substitutes from tarsal joints, the code presents minimal actionable procurement signals for business development targeting this specific service line.